Pharmacogenetic of Doxorubicin in HCC.

NCT06313047 · clinicaltrials.gov ↗

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Doxorubicin

Sponsor

Rehab Werida

Collaborators

[object Object]
[object Object]